Cargando…

Circulating Tumor DNA Testing Overcomes Limitations of Comprehensive Genomic Profiling from Tumor Tissue

“Liquid biopsy” is an established technique for examining circulating tumor DNA (ctDNA) from a routine blood draw and detecting actionable biomarkers. Nonetheless, ctDNA testing is rarely utilized for patients with newly diagnosed metastatic colorectal cancer (CRC). We report a case in which ctDNA t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Anivarya, Green, Michelle, Thacker, Julie, Jeck, William Richard, Strickler, John H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091230/ https://www.ncbi.nlm.nih.gov/pubmed/37064498 http://dx.doi.org/10.1159/000529813

Ejemplares similares

Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
por: Gao, Jing, et al.
Publicado: (2017)

Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors
por: Bonner, Erin R., et al.
Publicado: (2022)

Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA
por: Sunami, Kuniko, et al.
Publicado: (2021)

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
por: Guo, Qiaomei, et al.
Publicado: (2018)

Circulating Tumor DNA Testing for Liver Cancer
por: Furtado, Larissa V., et al.
Publicado: (2015)

Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience
por: Caputo, Vincenza, et al.
Publicado: (2022)

Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact
por: Noguchi, Tomoko, et al.
Publicado: (2020)

Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue
por: Leenanitikul, Julanee, et al.
Publicado: (2023)

Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer
por: Benavides, M., et al.
Publicado: (2022)

Clinical Circulating Tumor DNA Testing for Precision Oncology
por: Kim, Hyunji, et al.
Publicado: (2023)

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018)

Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer
por: Jie, Xiaoxiang, et al.
Publicado: (2022)

Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
por: Chikuie, Nobuyuki, et al.
Publicado: (2022)

Prospects for Comprehensive Analyses of Circulating Tumor Cells in Tumor Biology
por: Aoki, Masahiko, et al.
Publicado: (2020)

Prevalence of pathogenic germline variants in the circulating tumor DNA testing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2022)

Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice
por: Kim, Kyung-Hee, et al.
Publicado: (2023)

Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Burgener, Justin M., et al.
Publicado: (2021)

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients
por: Nguyen, Huu Thinh, et al.
Publicado: (2022)

Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab
por: Bruscaggin, Alessio, et al.
Publicado: (2021)

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
por: Zhu, Guanhua, et al.
Publicado: (2021)

Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia
por: Cortese, Rene, et al.
Publicado: (2014)

A Nanoparticle’s Journey to the Tumor: Strategies to Overcome First-Pass Metabolism and Their Limitations
por: Milligan, Joshua J., et al.
Publicado: (2022)

Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management
por: Sacco, Alessandra, et al.
Publicado: (2020)

Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer
por: Taavitsainen, Sinja, et al.
Publicado: (2019)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
por: Lee, Jieun, et al.
Publicado: (2017)

Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast Cancer
por: Huang, Chi-Cheng, et al.
Publicado: (2023)

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
por: Zhou, Cathy, et al.
Publicado: (2018)

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
por: Azzi, Georges, et al.
Publicado: (2022)

Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling
por: Grolleau, Emmanuel, et al.
Publicado: (2023)

Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients
por: Kfoury, Maria, et al.
Publicado: (2023)

Characterization of Factors Affecting the Detection Limit of EGFR p.T790M in Circulating Tumor DNA
por: Fahoum, Ibrahim, et al.
Publicado: (2018)

Assessing tumor heterogeneity: integrating tissue and circulating tumor DNA (ctDNA) analysis in the era of immuno-oncology - blood TMB is not the same as tissue TMB
por: Fridland, Stanislav, et al.
Publicado: (2021)

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment
por: Ma, Shenglin, et al.
Publicado: (2021)

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA
por: Kingston, Belinda, et al.
Publicado: (2021)

Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC
por: Wu, Jun, et al.
Publicado: (2022)

Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
por: Gao, Yang, et al.
Publicado: (2016)

Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q35lgkl6lkh1m5a1biovdsgv61